Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amarin says FDA won't reinstate special protocol assessment for ANCHOR study
Amarin says FDA won't reinstate special protocol assessment for ANCHOR study
Amarin says FDA won't reinstate special protocol assessment for ANCHOR study
Submitted by
admin
on January 21, 2014 - 8:12am
Source:
First Word Pharma
News Tags:
FDA
Amarin
Vascepa
Headline:
Amarin says FDA won't reinstate special protocol assessment for ANCHOR study
Do Not Allow Advertisers to Use My Personal information
